10 АНГЛІЙСЬКА КНИЖКИ ПОВ'ЯЗАНІ ІЗ «COAGULATION FACTOR»
Дізнайтеся про вживання
coagulation factor з наступної бібліографічної підбірки. Книжки пов'язані зі словом
coagulation factor та короткі уривки з них для забезпечення контексту його використання в англійська літературі.
1
Blood
Coagulation Factor Inhibitors—Advances in Research and ...
University. of. Toronto: Hypoperfusion. in. Severely. Injured. Trauma. Patients. is.
Associated. With. Reduced. Coagulation. Factor. Activity. According to the
authors of a study from Toronto, Canada, “Recent studies have shown that acute
...
2
Structural Determinants for Heparin Binding in Human ...
"Identification and chemical synthesis of a substrate-binding site for factor IX on
coagulation factor XIa." J Biol Chem 266(35): 24190-7. Baglia, F. A., B. A.
Jameson, et al. (1993). "Identification and characterization of a binding site for
factor XIIa ...
3
ACTIVATION OF BLOOD
COAGULATION FACTOR XIII AND INTERACTIONS ...
states.
THOMAS JOSEPH HORNYAK, 1992
4
SI Units for Clinical Measurement
Synonym Quantity coagulation factor VII factor VII coagulation factor VII (
functional) factor VII coagulation factor VIII factor VIII coagulation factor VIII (
functional) factor VIII activity coagulation factor IX (functional) factor IX activity
coagulation ...
Donald S. Young, Edward J. Huth, 1998
5
Mechanisms in Blood
Coagulation, Fibrinolysis and the ...
The contribution of Ca2"1" and phospholipids to the activation of human blood
coagulation factor X by activated factor IX. Biochem. J. 223, pp. 607 615. 354.
Mertens, K., Van Wijngaarden, A. & Bertina, R.M. (1985). The role of factor VIII in
the ...
6
Springer Handbook of Enzymes
... chains, carbohydrate attachment sites at positions 280, 286, 289, 309, 310,
and 318 [2]) [2] 5 Isolation/Preparation/Mutation/Application Source/tissue blood
plasma <1,2,4> (<4>, the high plasma 171 3.4.21.38 Coagulation factor Xlla.
Dietmar Schomburg, Ida Schomburg, Antje Chang, 2002
7
Blackwell's Five-Minute Veterinary Consult: Laboratory Tests ...
Coagulation factor deficiencies often cause severe bleeding. Factor deficiencies
most often develop secondary to an underlying disease process and will resolve
as the disease is treated. Those patients with hereditary factor deficiencies often
...
Shelly L. Vaden, Joyce S. Knoll, Francis W. K. Smith, Jr., 2011
8
Library of Congress Subject Headings
B56] BT Pregnancy—Complications Blood coagulation factor IX [RM 1 71.5] UF
Antihemophilic factor B Antiprothrombin II Christmas factor Coagulation factor IX
Factor IX Plasma thromboplastin component BT Blood coagulation factors Blood
...
Library of Congress. Cataloging Policy and Support Office, 2006
9
Handbook of Proteolytic Enzymes
... 1421, 2087 active site, 2087 Classical late-infantile neuronal ceroid
lipofuscinosis, 1886, 1891 Classical swine fever virus, 1401, 1781, 2134
Claudins, 1738 CLIP, 1088 Clip domain limulus clotting enzyme, 1744 limulus
coagulation factor B ...
Alan J. Barrett, J. Fred Woessner, Neil D. Rawlings, 2004
10
Coagulation Disorders: Diagnostic Standards of Care
A coagulation factor level may be low because there is decreased synthesis of
the factor or because there is an inhibitor of the factor. This differentiation is
essential because the treatment for a factor deficiency is usually very different
from the ...
НОВИНИ ІЗ ТЕРМІНОМ «COAGULATION FACTOR»
Дізнайтеся, що обговорювала національна та міжнародна преса, і як термін
coagulation factor вживається в контексті наступних новин.
Investors Alert: Targacept, Inc. (NASDAQ:TRGT), China Eastern …
... has gained positive results from a Phase I clinical trial for its coagulation Factor VIIa as a potential treatment for hemophilia A and B patients. «Stock Transcript, Липень 15»
Recent Press Release Updates: Blood Coagulation Factor Inhibitors …
The Report Blood Coagulation Factor Inhibitors – Pipeline Insights, 2015 provides information on pricing, market analysis, shares, forecast, and ... «Medgadget.com, Червень 15»
CardioBreak: Another Next-Gen TAVR Approval, Coagulants and …
An investigational long-acting recombinant coagulation factor IX with recombinant albumin (rIX-FP) had positive pivotal phase III data in ... «MedPage Today, Червень 15»
Today's Hottest: Alcatel Lucent SA (ADR) (NYSE:ALU), Google Inc …
... the potential buyer of Targacept, Inc. (NASDAQ:TRGT) said it has gained positive results from a Phase I clinical trial for its coagulation Factor ... «Property Mentor, Червень 15»
Conquering Hemophilia: Novo Nordisk Reports Encouraging Data …
... which has already been launched in 11 countries including in the U.S., is a B-domain truncated recombinant human coagulation factor VIII. «Benzinga, Червень 15»
Low-Energy Ultrasound Treatment Improves Regional Tumor Vessel …
... higher potential of these preapoptotic endothelial cells to activate coagulation via tTF-NGR and coagulation factor X as being a basis for this synergistic activity ... «Journal of Ultrasound in Medicine, Червень 15»
Cookies on Pharmiweb.Com
... its next-generation and long-acting coagulation Factor VIIa. ... 813d and support further clinical development of this coagulation factor for the ... «PharmiWeb.com, Червень 15»
CSL haemophilia drug closer to market after positive trials
The trials showed that CSL's recombinant coagulation factor IX, used to treat haemophilia B, and its single chain recombinant factor VIII, used to ... «The Australian Financial Review, Червень 15»
CSL Behring Presents rIX-FP for Hemophilia B Phase III Data …
CSL Behring selected albumin as its recombinant genetic fusion partner for its coagulation factor proteins due to its long physiological half-life. «Canada NewsWire, Червень 15»
In a Phase 3 Trial, Zonovate® Provided Long-term Efficacy and …
Zonovate® is a B-domain truncated recombinant human coagulation factor VIII for the treatment and prevention of bleeding in patients with ... «Canada NewsWire, Червень 15»
